Schulz Anselm, Dormagen Johann Baptist, Drolsum Anders, Bjørnbeth Bjørn Atle, Labori Knut Jørgen, Kløw Nils-Einar
Department of Radiology and Nuclear Medicine, Oslo University Hospital, Norway.
Acta Radiol. 2012 Dec 1;53(10):1081-7. doi: 10.1258/ar.2012.120049. Epub 2012 Oct 18.
Surgical treatment is the only option for long-term survival in patients with colorectal liver metastasis (CRLM). Contrast-enhanced CT and MRI are usually used for preoperative liver imaging. The initial surgical strategy for liver resection is based upon these findings. Further optimization of the surgical strategy by contrast-enhanced intraoperative ultrasound (CE-IOUS) might further improve the surgical outcome.
To evaluate the current impact of CE-IOUS with SonoVue(®) on the initial surgical strategy for CRLM.
Eighty-six consecutive patients undergoing open liver resection for CRLM were evaluated retrospectively over a 2.5-year period. The patients underwent 97 operations. Preoperative staging was performed with contrast-enhanced CT in all patients and MRI was available in 66 of 86 patients. CE-IOUS was performed in all patients according to a standardized examination technique. Curved array and linear transducers were used. CRLM were identified in venous phase as hypovascular lesions. CE-IOUS findings were compared with preoperative staging.
Combined CT/MRI identified preoperatively 328 CRLM (mean 3.4, range 0-14). Seventy-two additional lesions (18%) were identified in 38 patients during the operation. Intraoperatively 41 additional CRLM in 20 patients were identified by inspection, palpation, and CE-IOUS (10%), and another 31 CRLM in 17 patients were identified by CE-IOUS alone (8%). All additional CRLM detected by CE-IOUS were confirmed by histology if resection was performed. CE-IOUS changed planned operation strategy in 29.9% of operations. A larger resection was necessary in 13.4% of the cases, reduced liver resection was found sufficient in 11.3%, and 5.2% were found inoperable. For patients diagnosed preoperatively with solitary lesions CE-IOUS changed operation strategy in 19% and radical tumor resection would have failed in 4.8% without CE-IOUS.
CE-IOUS is essential to ensure optimal and complete tumor resection both in patient with solitary CRLM and multiple metastases.
手术治疗是结直肠癌肝转移(CRLM)患者长期生存的唯一选择。对比增强CT和MRI通常用于术前肝脏成像。肝切除的初始手术策略基于这些检查结果。通过对比增强术中超声(CE-IOUS)进一步优化手术策略可能会进一步改善手术效果。
评估使用声诺维(®)的CE-IOUS对CRLM初始手术策略的当前影响。
回顾性评估在2.5年期间连续86例接受CRLM肝切除术的患者。这些患者共接受了97次手术。所有患者均进行了术前增强CT分期,86例患者中有66例进行了MRI检查。所有患者均按照标准化检查技术进行CE-IOUS检查。使用了弯阵探头和线阵探头。CRLM在静脉期表现为低血供病变。将CE-IOUS检查结果与术前分期进行比较。
CT/MRI联合检查术前共发现328个CRLM(平均3.4个,范围0 - 14个)。术中在38例患者中又发现了72个额外病灶(18%)。术中通过视诊、触诊和CE-IOUS在20例患者中发现了另外41个CRLM(10%),仅通过CE-IOUS在17例患者中发现了另外31个CRLM(8%)。如果进行了切除,所有通过CE-IOUS检测到的额外CRLM均经组织学证实。CE-IOUS改变了29.9%手术的计划手术策略。13.4%的病例需要进行更大范围的切除,11.3%的病例发现缩小肝切除已足够,5.2%的病例发现无法手术切除。对于术前诊断为孤立性病灶的患者,CE-IOUS改变了19%的手术策略,若没有CE-IOUS,4.8%的患者根治性肿瘤切除将会失败。
CE-IOUS对于确保孤立性CRLM和多发转移患者实现最佳和完整的肿瘤切除至关重要。